Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By boosting these receptors, Retatrutide reduces hunger pangs, {promotesinsulin secretion, and ultimately leads to significant reduction in body mass. While studi